Clinical Procedures to Support Research in ALS
NCT03489278 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2026-03-23
Summary
The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.
Conditions
- Amyotrophic Lateral Sclerosis
- ALS-Frontotemporal Dementia
- Primary Lateral Sclerosis
- Progressive Muscular Atrophy
Sponsors & Collaborators
-
Muscular Dystrophy Association
collaborator OTHER -
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
National Center for Advancing Translational Sciences (NCATS)
collaborator NIH -
National Institutes of Health (NIH)
collaborator NIH -
University of Miami
lead OTHER
Principal Investigators
-
Michael Benatar, MBChB, MS, DPhil · University of Miami
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-15
- Primary Completion
- 2026-06-30
- Completion
- 2027-06-30
Countries
- United States
Study Locations
More Related Trials
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235 ·Status: RECRUITING
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
Intermuscular Coherence as a Biomarker for ALS
NCT05104710 ·Status: RECRUITING
-
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713 ·Status: TERMINATED ·Phase: NA
-
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390 ·Status: COMPLETED
-
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
NCT01492686 ·Status: COMPLETED ·Phase: PHASE3
-
Delineating Swallowing Impairment and Decline in ALS
NCT02962050 ·Status: COMPLETED
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420 ·Status: RECRUITING
-
Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)
NCT00838617 ·Status: COMPLETED
-
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
NCT00718458 ·Status: COMPLETED
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis
NCT04455542 ·Status: COMPLETED
-
ALS/MND Natural History Study Data Repository
NCT05966038 ·Status: RECRUITING
-
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
NCT02327845 ·Status: ENROLLING_BY_INVITATION
-
Determining the Safety of L-serine in ALS
NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of ALS Reversals 4: LifeTime Exposures
NCT03706391 ·Status: COMPLETED
-
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
NCT00317616 ·Status: RECRUITING
-
Digital Assessment of Speech and Fine Motor Control in ALS
NCT06315673 ·Status: RECRUITING
-
A Pilot Study of Biomarkers for Spinal Muscular Atrophy
NCT00756821 ·Status: COMPLETED
-
Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
NCT00302198 ·Status: COMPLETED
-
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
NCT02895789 ·Status: COMPLETED
-
Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.
NCT01051882 ·Status: COMPLETED ·Phase: PHASE1/PHASE2